
APURES CO., LTD. — Investor Relations & Filings
APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 기타시장안내 (상장폐지 절차 진행 안내) | 2026-05-07 | Korean | |
| 주권매매거래정지해제 (상장폐지에 따른 정리매매 개시) | 2026-05-07 | Korean | |
| 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | |
| 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | |
| 정기주주총회결과 | 2026-03-31 | Korean | |
| 지정자문인선임계약의해지 | 2026-03-24 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42656701 | 기타시장안내 (상장폐지 절차 진행 안내) | 2026-05-07 | Korean | ||
| 42656667 | 주권매매거래정지해제 (상장폐지에 따른 정리매매 개시) | 2026-05-07 | Korean | ||
| 34380654 | 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | ||
| 34379242 | 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | ||
| 33116515 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33020169 | 지정자문인선임계약의해지 | 2026-03-24 | Korean | ||
| 33020113 | 주권매매거래정지기간변경 (지정자문인 계약해지) | 2026-03-24 | Korean | ||
| 33020111 | 기타시장안내 (지정자문인 계약해지) | 2026-03-24 | Korean | ||
| 33013934 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
| 33012105 | 주권매매거래정지 (상장폐지사유발생) | 2026-03-23 | Korean | ||
| 33012103 | 감사보고서제출 | 2026-03-23 | Korean | ||
| 33012096 | 기타시장안내 (상장폐지 관련) | 2026-03-23 | Korean | ||
| 33012074 | [기재정정]주주총회소집결의 | 2026-03-23 | Korean | ||
| 32953912 | 주주총회소집공고 | 2026-03-16 | Korean | ||
| 32921521 | 주주총회소집결의 | 2026-03-10 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biomark Diagnostics Inc.
Oncology liquid biopsy diagnostics using metabolomics and A…
|
BUX | CA | Professional, scientific and te… |
|
Biomind Labs
Developing novel pharmaceutical drugs for patients with neu…
|
BMND | CA | Professional, scientific and te… |
|
BioNexus Gene Lab Corp
Develops gene-based diagnostics for early detection of dise…
|
BGLC | US | Professional, scientific and te… |
|
Biophytis S.A.
Clinical-stage biotech developing therapeutics for age-rela…
|
ALBPS | FR | Professional, scientific and te… |
|
BioRestorative Therapies, Inc.
Develops adult stem cell therapies for degenerative disc an…
|
BRTX | US | Professional, scientific and te… |
|
BioSenic SA
Develops therapies for autoimmune diseases, inflammation, a…
|
BIOS | BE | Professional, scientific and te… |
|
BIOTECH
A biotechnology group offering preclinical services, intein…
|
BST | ES | Professional, scientific and te… |
|
BIOTRON LIMITED
Clinical-stage developer of small molecule antiviral drugs …
|
BIT | AU | Professional, scientific and te… |
|
BioVaxys Technology Corp.
Clinical-stage biopharma developing novel immunotherapy ass…
|
BIOV | CA | Professional, scientific and te… |
|
Biovica International B
Develops blood-based biomarker assays for cancer therapy mo…
|
BIOVIC | SE | Professional, scientific and te… |
APURES CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15871/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15871 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15871 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15871 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15871}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for APURES CO., LTD. (id: 15871)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.